- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 419
Dren Bio draws $60m from investors
Taiho Ventures and SR One co-led a series A round that will fund the early clinical progress of Dren's cancer and protein-depletion drug candidates.
Oct 20, 2020Azitra aces $17m series B round
The round was led by $8m from Leaps by Bayer and increased the microbiome skin treatment developer's total funding to $34m.
Oct 20, 2020Knowledgehook picks up series A funding
Nelson Education participated in a $15.2m round for Knowledgehook, which is mulling the expansion of its maths learning assessement platform to other subjects.
Oct 20, 2020Disarm hands itself to Eli Lilly
Eli Lilly will acquire the WUSTL-linked neurological disease therapy developer in a $135m deal that could top $1.2bn with milestone payments.
Oct 19, 2020Aligos accesses public markets with $150m
Roche and Novo-backed small molecule therapy developer Aligos Therapeutics has floated in an initial public offering priced in the middle of its range.
Oct 19, 2020Eargo steers its way to $141m IPO
Nan Fung-backed hearing aid producer Eargo's shares opened at double its IPO price after it floated above its range.
Oct 19, 2020Disarm hands itself to Eli Lilly
Eli Lilly will acquire the AbbVie-backed neurological disease therapy developer in a $135m transaction that could top $1.2bn with milestone payments.
Oct 19, 2020Fluence adds Advanced Microgrid in acquisition deal
AMS, a developer of energy value assessment software, had raised $52m from investors including Engie, AGL Energy, Southern Company and GE Ventures.
Oct 19, 2020Argyle arcs to $20m series A
Checkr reinvested in the income verification software startup having co-led its seed round just over a year ago.
Oct 19, 2020Agility Robotics escorts investors to $20m round
TDK Ventures and Sony Innovation Fund took part in a series A round that will support the distribution of Agility's warehouse robots.
Oct 19, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


